FDA Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs
Title:
FDA Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs
Origin/Publisher:
FDA
Content:
This guidance recommends steps manufacturers of APIs and drug products should take to detectand prevent unacceptable levels of nitrosamine2 impurities in pharmaceutical products